PFE and JNJ Annual Dividend Income of $3,540 for Investors

Investors holding 500 shares each of Pfizer (PFE) and Johnson & Johnson (JNJ) can expect an annual passive income of $3,540 on a $127,000 investment, with a blended yield of 2.79%. JNJ recently increased its quarterly dividend to $1.34, marking its 64th consecutive increase, supported by a AAA-rated balance sheet and $19.7 billion in free cash flow. Meanwhile, PFE's yield stands at 6.8%, reflecting stock compression. JNJ reported Q1 2026 revenues of $15.426 billion in pharmaceuticals, an 11.2% year-over-year increase, while MedTech revenue reached $8.636 billion, up 7.7%.